Brett Baker
Clinical Cardiac Electrophysiology · Mt Pleasant, SCNPI 1861458853
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 63.8% of it on its own, with 30 other manufacturers making up the rest.
Across 453 payments — averaging $187.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$54K
- Pfizer$12K
- E.r. Squibb & Sons, L.L.C.$9K
- Abbott$2K
- Biotronik Inc.$2K
- Boston Scientific$2K
- plus $4K from 25 others
What the payments were for
- Consulting fees$1,1001%
- Speaking & faculty fees$48,08057%
- Travel & lodging$23,34127%
- Food & beverage$12,44615%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 99 | $54,246 |
| Pfizer | 30 | $11,811 |
| E.r. Squibb & Sons, L.L.C. | 37 | $8,740 |
| Abbott | 43 | $2,316 |
| Biotronik Inc. | 40 | $2,182 |
| Boston Scientific | 48 | $1,736 |
| CMS Imaging, Inc. | 6 | $767 |
| Atricure, Inc. | 15 | $561 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 34 | $557 |
| Johnson & Johnson | 24 | $319 |
| Philips North America LLC | 4 | $312 |
| Siemens Medical Solutions USA, Inc. | 2 | $226 |
| Actelion Pharmaceuticals US, Inc. | 22 | $215 |
| Vital Connect, Inc | 3 | $169 |
| Amgen | 8 | $159 |
| Novartis | 8 | $135 |
| Boehringer Ingelheim | 6 | $101 |
| Sanofi-aventis U.S. LLC | 4 | $75 |
| Merck | 4 | $73 |
| Novo Nordisk | 2 | $43 |
| BD | 1 | $42 |
| Altathera Pharmaceuticals LLC | 1 | $29 |
| Edwards Lifesciences | 1 | $21 |
| Cardiva Medical, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Cvrx, Inc. | 1 | $20 |
| Bardy Diagnostics, Inc. | 4 | $18 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Cardinal Health 200 LLC | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Lexicon Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$19,119
- AFFERA MAPPING SYSTEM$3,900
- Watchman$746
- ENSITE PRECISION$608
- EnSite Precision Cardiac Mapping System$380
- Selectra$304
- PulseSelect$297
- WATCHMAN Access System$287
- Acticor 7 VR-T DX$273
- AMPLATZER AMULET$268
- (5091) Amb Mon & Diag Und$266
- Arctic Front$214
- AZURE XT DR MRI SURESCAN$175
- EPI-SENSE GUIDED COAGULATION SYS$175
- ATRICURE ATRICLIP LAA EXCLUSION$175
- AURORA EV-ICD MRI SURESCAN$144
- AMPLATZER$144
- ARCTIC FRONT ADVANCE$144
How this compares
$84,975 in reported general payments places this provider in the 75th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.
See all clinical cardiac electrophysiology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 102 | $109,731 |
| Metoprolol Succinate | 54 | $840 |
| Amiodarone Hcl | 35 | $780 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 21 | $741 |
| ClopidogrelClopidogrel Bisulfate | 33 | $355 |
| Pantoprazole Sodium | 11 | $135 |
| Carvedilol | 18 | $132 |
| Tramadol Hcl | 35 | $71 |
| Metoprolol Tartrate | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $11,811 | $109,731102 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.
Other clinical cardiac electrophysiology in Mt Pleasant
- Bryan FrainMt Pleasant$11K
- Jeffrey WinterfieldCharleston$498K
- Frank CuocoCharleston$306K
- Anne KromanCharleston$279K
- Andrew BrenyoRock Hill$241K
- Joseph ManfrediGreenville$213K
- Michael GoldCharleston$204K
- Sultan SiddiqueColumbia$182K
- Peter NetzlerGreenville$146K
- Yuxuan MaoLittle River$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.